Protab

Developing immunotherapeutic mAb for autoimmune inflammatory diseases

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2005 language protab.co.il

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 159 times.

YearFilings
20122
20131
20142
20151
20161
20171
20181
20191
20211

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon